Literature DB >> 17330845

Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer.

Yoshinori Mori1, Hiromi Kataoka, Yutaka Miura, Makoto Kawaguchi, Eiji Kubota, Naotaka Ogasawara, Tadayuki Oshima, Satoshi Tanida, Makoto Sasaki, Hirotaka Ohara, Tsutomu Mizoshita, Masae Tatematsu, Kiyofumi Asai, Takashi Joh.   

Abstract

Human gastric epithelium has a unique mucin gene expression pattern, which becomes markedly altered in gastrointestinal disorder. This alteration in mucin expression, including the mucin MUC5AC, may be related to the development and prognosis of gastric cancers, and MUC5AC-positive gastric cancer has been reported to be poor prognosis. However, the molecular mechanism of MUC5AC transcriptional regulation has not been fully elucidated. AT motif-binding factor 1 (ATBF1) is a homeotic transcriptional regulatory factor recently identified as a tumor suppressor gene, and its subcellular localization suggests a link to cell proliferation and differentiation. We investigated the mechanism of MUC5AC transcriptional regulation by ATBF1. In 123 gastric cancer lesions, ATBF1 expressed in the nucleus significantly suppressed MUC5AC expression, as determined by immunohistochemistry. In addition, analysis of the MUC5AC promoter region revealed an AT motif-like element. This element was found to be essential for ATBF1 suppression of MUC5AC promoter activity as shown in a dual luciferase-reporter assay. Over-expressed ATBF1 also significantly suppressed endogenous MUC5AC protein expression in gastric cancer cells. Chromatin immunoprecipitation demonstrated that ATBF1 binds to the AT motif-like element in the MUC5AC promoter. These results indicate that ATBF1 in the nucleus negatively regulates the MUC5AC gene in gastric cancer by binding to an AT motif-like element in the MUC5AC promoter. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17330845     DOI: 10.1002/ijc.22654

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Heterozygous deletion of Atbf1 by the Cre-loxP system in mice causes preweaning mortality.

Authors:  Xiaodong Sun; Xiaoying Fu; Jie Li; Changsheng Xing; David W Martin; Helen Heju Zhang; Zhengjia Chen; Jin-Tang Dong
Journal:  Genesis       Date:  2012-06-21       Impact factor: 2.487

2.  Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.

Authors:  Xue-Yuan Dong; Peng Guo; Xiaodong Sun; Qunna Li; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

3.  Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP.

Authors:  Xue-Yuan Dong; Xiaoying Fu; Songqing Fan; Peng Guo; Dan Su; Jin-Tang Dong
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

4.  Identification of Drosophila Zfh2 as a Mediator of Hypercapnic Immune Regulation by a Genome-Wide RNA Interference Screen.

Authors:  Iiro Taneli Helenius; Ryan J Haake; Yong-Jae Kwon; Jennifer A Hu; Thomas Krupinski; S Marina Casalino-Matsuda; Peter H S Sporn; Jacob I Sznajder; Greg J Beitel
Journal:  J Immunol       Date:  2015-12-07       Impact factor: 5.422

5.  Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.

Authors:  Jie Yang
Journal:  Med Oncol       Date:  2020-03-27       Impact factor: 3.064

6.  Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma.

Authors:  Xiaodong Sun; Jie Li; Gabriel Sica; Song-Qing Fan; Yuxiang Wang; Zhengjia Chen; Susan Muller; Zhuo Georgia Chen; Xiaoying Fu; Xue-Yuan Dong; Peng Guo; Dong M Shin; Jin-Tang Dong
Journal:  Head Neck       Date:  2012-07-13       Impact factor: 3.147

7.  Characterization of nuclear localization and SUMOylation of the ATBF1 transcription factor in epithelial cells.

Authors:  Xiaodong Sun; Jie Li; Frederick N Dong; Jin-Tang Dong
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

8.  The Regulatory Factor ZFHX3 Modifies Circadian Function in SCN via an AT Motif-Driven Axis.

Authors:  Michael J Parsons; Marco Brancaccio; Siddharth Sethi; Elizabeth S Maywood; Rahul Satija; Jessica K Edwards; Aarti Jagannath; Yvonne Couch; Mattéa J Finelli; Nicola J Smyllie; Christopher Esapa; Rachel Butler; Alun R Barnard; Johanna E Chesham; Shoko Saito; Greg Joynson; Sara Wells; Russell G Foster; Peter L Oliver; Michelle M Simon; Ann-Marie Mallon; Michael H Hastings; Patrick M Nolan
Journal:  Cell       Date:  2015-07-30       Impact factor: 41.582

9.  Adalimumab Treatment in Biologically Naïve Crohn's Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement.

Authors:  Tsutomu Mizoshita; Satoshi Tanida; Hironobu Tsukamoto; Keiji Ozeki; Takahito Katano; Hirotaka Nishiwaki; Masahide Ebi; Yoshinori Mori; Eiji Kubota; Hiromi Kataoka; Takeshi Kamiya; Takashi Joh
Journal:  Gastroenterol Res Pract       Date:  2014-04-16       Impact factor: 2.260

10.  Deletion of atbf1/zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways.

Authors:  Xiaodong Sun; Xiaoying Fu; Jie Li; Changsheng Xing; Henry F Frierson; Hao Wu; Xiaokun Ding; Tongzhong Ju; Richard D Cummings; Jin-Tang Dong
Journal:  Neoplasia       Date:  2014-06-14       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.